Can These Companies Bounce Back from Disappointing Sales?

Bristol-Myers Squibb (NYSE: BMY  ) and Pfizer (NYSE: PFE  ) have rallied back from the patent cliff as well as any companies in big pharma, and both these standout firms have looked toward the future in igniting investor optimism. But one drug captured all the hype around these two companies before its approval in the final days of 2012: blood thinner Eliquis.

Yet Eliquis hasn't met those high hopes in its first full year on the market. The drug's managed tepid sales at best, and Wall Street analysts have toned down 2014's expectations for Eliquis, a drug that once garnered peak sales estimates of up to $4 billion annually. Bristol and Pfizer aren't giving up on this promising yet sluggish therapy, but will Eliquis turn things around for investors cautious about the drug's future?

Eliquis's most recent approval might be the first spark of hope for this drug after a slow market debut. Find out how this promising drug can mount a comeback in the video below, as Motley Fool contributor Dan Carroll takes you through the latest on Eliquis -- and whether or not Pfizer, Bristol, and investors can rely on this ballyhooed medication to emerge as a blockbuster powerhouse in the future.

Big pharma's best-kept secret
Big pharma stocks like Bristol and Pfizer have enjoyed years of success, but one under-the-radar key makes these stocks a huge opportunity for your portfolio: Their high-yielding dividends. One of the dirty secrets that few finance professionals will openly admit is the fact that dividend stocks as a group handily outperform their non-dividend paying brethren. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2882968, ~/Articles/ArticleHandler.aspx, 10/1/2014 2:24:09 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement